Skip to main navigation
Skip to search
Skip to main content
University of Birmingham Home
Help & FAQ
Home
Research output
Profiles
Research units
Projects
Activities
Datasets
Equipment
Prizes
Press/Media
Search by expertise, name or affiliation
Cannabinoids for Tourette's Syndrome.
A Curtis,
Carl Clarke
,
Hugh Rickards
Medicine and Health
Research output
:
Contribution to journal
›
Article
33
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Cannabinoids for Tourette's Syndrome.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Adjuvant Therapy
16%
AMED
16%
Cannabinoids
100%
CINAHL
16%
Cochrane Central Register of Controlled Trials
16%
Cochrane Library
16%
Cochrane Review
33%
Compulsive Behavior
16%
Drug Use
16%
Embase
16%
Fluoxetine
16%
Gilles De La Tourette Syndrome
16%
Group Studies
16%
Inclusion Criteria
16%
Issue 4
16%
MEDLINE
16%
Monotherapy
16%
Motor Tics
16%
Neuropsychiatric Disorders
16%
Nursing
16%
Obsessive-compulsive Behavior
16%
Obsessive-compulsive Symptoms
33%
Phonic Tic
16%
Placebo
50%
Premonitory Urge
16%
PsycINFO
16%
Randomized Controlled Trial
16%
Tic Frequency
16%
Tic Severity
16%
Tourette Syndrome
100%
Δ9-tetrahydrocannabinol (Δ9-THC)
33%
Pharmacology, Toxicology and Pharmaceutical Science
Cannabinoid
100%
Dronabinol
28%
Fluoxetine
14%
Gilles De La Tourette Syndrome
100%
Monotherapy
14%
Placebo
42%
Randomized Controlled Trial
14%
Side Effect
14%
Tic
100%
Neuroscience
Adjuvant Therapy
16%
Cannabinoid
100%
Compulsive Behavior
33%
Fluoxetine
16%
Placebo
50%
Randomized Controlled Trial
16%
Tetrahydrocannabinol
33%
Tourette Syndrome
100%